BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 7937230)

  • 1. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group.
    Neuzner J
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1243-55. PubMed ID: 7937230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination biphasic waveform plus sequential pulse defibrillation improves defibrillation efficacy of a nonthoracotomy lead system.
    Exner D; Yee R; Jones DL; Klein GJ; Mehra R
    J Am Coll Cardiol; 1994 Feb; 23(2):317-22. PubMed ID: 8294680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in defibrillation threshold in non-thoracotomy implantable defibrillators using a biphasic waveform.
    Martin DT; John R; Venditti FJ
    Am J Cardiol; 1995 Aug; 76(4):263-6. PubMed ID: 7618621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: comparison with a standard monophasic device using the same lead system.
    Natale A; Sra J; Axtell K; Maglio C; Dhala A; Deshpande S; Jazayeri M; Wase A; Akhtar M
    J Am Coll Cardiol; 1994 Aug; 24(2):406-12. PubMed ID: 8034875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First experience with a new nonthoracotomy defibrillation lead system.
    Trappe HJ; Pfitzner P; Wenzlaff P; Fain E; Fieguth HG
    Am Heart J; 1996 Sep; 132(3):599-607. PubMed ID: 8800031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of device activation for ventricular arrhythmias and survival in patients with implantable pacemakers/defibrillators. CADENCE Investigators.
    Reiter MJ; Fain ES; Senelly KM; Robertson AD
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1487-98. PubMed ID: 7991419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial and nonthoracotomy defibrillation lead systems combined with a cardioverter defibrillator.
    Trappe HJ; Fieguth HG; Pfitzner P; Heintze J; Wenzlaff P; Kielblock B
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):127-32. PubMed ID: 7724385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds.
    Kudenchuk PJ; Poole JE; Dolack GL; Gleva MJ; Anderson J; Troutman C; Bardy GH
    J Cardiovasc Electrophysiol; 1997 May; 8(5):485-95. PubMed ID: 9160224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of biphasic waveform pulse on endocardial defibrillation efficacy in humans.
    Neuzner J; Pitschner HF; Huth C; Schlepper M
    Pacing Clin Electrophysiol; 1994 Feb; 17(2):207-12. PubMed ID: 7513406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans.
    Block M; Hammel D; Böcker D; Borggrefe M; Budde T; Isbruch F; Wietholt D; Scheld HH; Breithardt G
    J Cardiovasc Electrophysiol; 1994 Jul; 5(7):581-90. PubMed ID: 7987528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
    Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF
    J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up].
    Boriani G; Frabetti L; Capucci A; Galli R; Parlapiano M; Biffi M; Sabbatani P; Spedicato L; Bronzetti G; Pierangeli A
    Cardiologia; 1995 Jun; 40(6):381-9. PubMed ID: 8640850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.